| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 4.99e-06 | 5 | 160 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | ethanol binding | 9.92e-06 | 6 | 160 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 1.73e-05 | 7 | 160 | 3 | GO:0035005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 1.73e-05 | 7 | 160 | 3 | GO:0046934 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 5.17e-05 | 26 | 160 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 7.95e-05 | 11 | 160 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 7.95e-05 | 11 | 160 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 1.72e-04 | 14 | 160 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 1.72e-04 | 14 | 160 | 3 | GO:0000340 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 3.19e-04 | 41 | 160 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | RNA cap binding | 6.04e-04 | 21 | 160 | 3 | GO:0000339 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 6.28e-04 | 5 | 160 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication | 6.28e-04 | 5 | 160 | 2 | GO:0086083 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 6.28e-04 | 5 | 160 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 7.95e-04 | 23 | 160 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 9.03e-04 | 24 | 160 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1.02e-03 | 25 | 160 | 3 | GO:0016702 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.15e-03 | 26 | 160 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.15e-03 | 26 | 160 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.15e-03 | 26 | 160 | 3 | GO:0016701 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.28e-03 | 59 | 160 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.28e-03 | 59 | 160 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.58e-03 | 29 | 160 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.75e-03 | 30 | 160 | 3 | GO:0018455 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 4.58e-07 | 3 | 160 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 4.53e-06 | 5 | 160 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 4.53e-06 | 5 | 160 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 7.67e-06 | 17 | 160 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 9.80e-06 | 18 | 160 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 2.29e-05 | 22 | 160 | 4 | GO:0036092 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 2.49e-05 | 8 | 160 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.75e-05 | 23 | 160 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 3.11e-05 | 47 | 160 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 3.28e-05 | 24 | 160 | 4 | GO:0048015 | |
| GeneOntologyBiologicalProcess | SCF complex assembly | 5.98e-05 | 2 | 160 | 2 | GO:0010265 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 8.67e-05 | 93 | 160 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 9.32e-05 | 31 | 160 | 4 | GO:0046184 | |
| GeneOntologyBiologicalProcess | ADP transport | 9.57e-05 | 12 | 160 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | Rac protein signal transduction | 1.02e-04 | 60 | 160 | 5 | GO:0016601 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol phosphate biosynthetic process | 1.61e-04 | 66 | 160 | 5 | GO:0046854 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.95e-04 | 15 | 160 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.95e-04 | 153 | 160 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | T cell selection | 1.99e-04 | 69 | 160 | 5 | GO:0045058 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 2.10e-04 | 38 | 160 | 4 | GO:1901524 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.59e-04 | 73 | 160 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 2.88e-04 | 17 | 160 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | mitophagy | 2.94e-04 | 75 | 160 | 5 | GO:0000423 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.32e-04 | 167 | 160 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | positive regulation of Rac protein signal transduction | 3.43e-04 | 18 | 160 | 3 | GO:0035022 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 3.64e-05 | 9 | 161 | 3 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 3.64e-05 | 9 | 161 | 3 | GO:0005943 | |
| MousePheno | abnormal vitamin metabolism | 7.95e-06 | 15 | 126 | 4 | MP:0013244 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 7.95e-06 | 15 | 126 | 4 | MP:0013274 | |
| MousePheno | abnormal vitamin A metabolism | 7.95e-06 | 15 | 126 | 4 | MP:0011233 | |
| MousePheno | abnormal ethanol metabolism | 1.40e-05 | 6 | 126 | 3 | MP:0005443 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | IPPK AGO2 DSP POLE POT1 TOPBP1 REV3L STAT3 URB1 CYFIP1 HMCN1 PIK3CB PI4KA VPS35L TTI1 ZFR TASOR SNRNP200 PLK4 TPI1 | 1.80e-05 | 772 | 126 | 20 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | IPPK AGO2 DSP POLE POT1 TOPBP1 REV3L STAT3 URB1 CYFIP1 HMCN1 PIK3CB PI4KA VPS35L TTI1 ZFR TASOR SNRNP200 PLK4 TPI1 | 2.06e-05 | 779 | 126 | 20 | MP:0014257 |
| MousePheno | abnormal retinol metabolism | 2.44e-05 | 7 | 126 | 3 | MP:0005444 | |
| MousePheno | embryonic lethality between implantation and placentation, complete penetrance | IPPK AGO2 DSP POLE POT1 REV3L STAT3 CYFIP1 PIK3CB PI4KA VPS35L TTI1 ZFR PLK4 TPI1 | 4.98e-05 | 506 | 126 | 15 | MP:0011095 |
| MousePheno | embryonic lethality between implantation and placentation | IPPK AGO2 DSP POLE POT1 REV3L STAT3 CYFIP1 PIK3CB PI4KA VPS35L TTI1 ZFR PLK4 TPI1 | 1.70e-04 | 565 | 126 | 15 | MP:0009850 |
| Domain | ARM-type_fold | DOCK2 CAND1 CAND2 BZW2 NEK10 TSC2 APOB SPAG6 RIF1 URB1 PIK3CA PIK3CB PIK3CG PI4KA TTC12 TTI1 | 1.79e-08 | 339 | 152 | 16 | IPR016024 |
| Domain | PI3Ka | 5.15e-07 | 9 | 152 | 4 | PF00613 | |
| Domain | PI3Ka | 5.15e-07 | 9 | 152 | 4 | SM00145 | |
| Domain | - | 5.15e-07 | 9 | 152 | 4 | 1.25.40.70 | |
| Domain | PI_Kinase | 8.52e-07 | 10 | 152 | 4 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 8.52e-07 | 10 | 152 | 4 | IPR001263 | |
| Domain | PIK_HELICAL | 8.52e-07 | 10 | 152 | 4 | PS51545 | |
| Domain | PI3K_ABD | 2.10e-06 | 4 | 152 | 3 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 2.10e-06 | 4 | 152 | 3 | IPR003113 | |
| Domain | PI3/4_kinase_CS | 5.37e-06 | 15 | 152 | 4 | IPR018936 | |
| Domain | - | 7.11e-06 | 16 | 152 | 4 | 1.10.1070.11 | |
| Domain | PI3Kc | 7.11e-06 | 16 | 152 | 4 | SM00146 | |
| Domain | PI3_PI4_kinase | 1.18e-05 | 18 | 152 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.18e-05 | 18 | 152 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.18e-05 | 18 | 152 | 4 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.18e-05 | 18 | 152 | 4 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.18e-05 | 18 | 152 | 4 | PS50290 | |
| Domain | PI3K_Ras-bd_dom | 1.81e-05 | 7 | 152 | 3 | IPR000341 | |
| Domain | PI3K_rbd | 1.81e-05 | 7 | 152 | 3 | SM00144 | |
| Domain | PI3K_rbd | 1.81e-05 | 7 | 152 | 3 | PF00794 | |
| Domain | PI3K_RBD | 1.81e-05 | 7 | 152 | 3 | PS51546 | |
| Domain | PI3K_C2 | 2.87e-05 | 8 | 152 | 3 | SM00142 | |
| Domain | ADH_Zn_CS | 2.87e-05 | 8 | 152 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 2.87e-05 | 8 | 152 | 3 | PS00059 | |
| Domain | PI3K_C2_dom | 2.87e-05 | 8 | 152 | 3 | IPR002420 | |
| Domain | PI3K_C2 | 2.87e-05 | 8 | 152 | 3 | PF00792 | |
| Domain | PI3K_C2 | 2.87e-05 | 8 | 152 | 3 | PS51547 | |
| Domain | Cytoplasmic_FMR1-int | 6.58e-05 | 2 | 152 | 2 | IPR008081 | |
| Domain | TATA-bd_TIP120 | 6.58e-05 | 2 | 152 | 2 | IPR013932 | |
| Domain | FragX_IP | 6.58e-05 | 2 | 152 | 2 | PF05994 | |
| Domain | TIP120 | 6.58e-05 | 2 | 152 | 2 | PF08623 | |
| Domain | Mit_uncoupling | 1.10e-04 | 12 | 152 | 3 | IPR002030 | |
| Domain | Ubiquitin-rel_dom | 1.34e-04 | 184 | 152 | 8 | IPR029071 | |
| Domain | ATPase_dyneun-rel_AAA | 1.80e-04 | 14 | 152 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.80e-04 | 14 | 152 | 3 | PF07728 | |
| Domain | BPS-dom | 1.96e-04 | 3 | 152 | 2 | IPR015042 | |
| Domain | PI3K_p85B | 1.96e-04 | 3 | 152 | 2 | PF02192 | |
| Domain | PI3K_p85B | 1.96e-04 | 3 | 152 | 2 | SM00143 | |
| Domain | Vitellinogen_superhlx | 1.96e-04 | 3 | 152 | 2 | IPR011030 | |
| Domain | BPS | 1.96e-04 | 3 | 152 | 2 | PF08947 | |
| Domain | PKS_ER | 2.74e-04 | 16 | 152 | 3 | IPR020843 | |
| Domain | ADH_N | 2.74e-04 | 16 | 152 | 3 | PF08240 | |
| Domain | PKS_ER | 2.74e-04 | 16 | 152 | 3 | SM00829 | |
| Domain | ADH_N | 2.74e-04 | 16 | 152 | 3 | IPR013154 | |
| Domain | ARM-like | 3.75e-04 | 270 | 152 | 9 | IPR011989 | |
| Domain | DUF1394 | 3.91e-04 | 4 | 152 | 2 | IPR009828 | |
| Domain | DNA_pol_B | 3.91e-04 | 4 | 152 | 2 | PF00136 | |
| Domain | DUF1394 | 3.91e-04 | 4 | 152 | 2 | PF07159 | |
| Domain | DNA-dir_DNA_pol_B | 3.91e-04 | 4 | 152 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 3.91e-04 | 4 | 152 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 3.91e-04 | 4 | 152 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 3.91e-04 | 4 | 152 | 2 | PF03104 | |
| Domain | POLBc | 3.91e-04 | 4 | 152 | 2 | SM00486 | |
| Domain | - | 3.94e-04 | 18 | 152 | 3 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 4.65e-04 | 19 | 152 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 4.65e-04 | 19 | 152 | 3 | IPR002085 | |
| Domain | ADH_C | 4.65e-04 | 19 | 152 | 3 | IPR013149 | |
| Domain | - | 4.76e-04 | 222 | 152 | 8 | 1.25.10.10 | |
| Domain | GroES-like | 9.43e-04 | 24 | 152 | 3 | IPR011032 | |
| Domain | - | 1.34e-03 | 148 | 152 | 6 | 2.60.40.150 | |
| Domain | Aden_trnslctor | 1.49e-03 | 28 | 152 | 3 | IPR002113 | |
| Domain | RA | 2.01e-03 | 31 | 152 | 3 | SM00314 | |
| Domain | Mit_carrier | 2.20e-03 | 32 | 152 | 3 | IPR002067 | |
| Domain | C2_dom | 2.26e-03 | 164 | 152 | 6 | IPR000008 | |
| Domain | PH | 2.74e-03 | 229 | 152 | 7 | PF00169 | |
| Domain | RA | 3.10e-03 | 36 | 152 | 3 | PF00788 | |
| Domain | - | SAMD9 MYO7A DYNC2H1 ABCC9 SLFN5 SULT1C4 DRG1 MDN1 EIF2S3 MOV10L1 NMRK1 CARD11 DNAH6 SNRNP200 | 3.13e-03 | 746 | 152 | 14 | 3.40.50.300 |
| Domain | RA | 3.35e-03 | 37 | 152 | 3 | PS50200 | |
| Domain | ZU5 | 4.12e-03 | 12 | 152 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.12e-03 | 12 | 152 | 2 | IPR000906 | |
| Domain | RA_dom | 4.19e-03 | 40 | 152 | 3 | IPR000159 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.62e-03 | 14 | 152 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.62e-03 | 14 | 152 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.62e-03 | 14 | 152 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.62e-03 | 14 | 152 | 2 | PF08393 | |
| Domain | MT | 5.62e-03 | 14 | 152 | 2 | PF12777 | |
| Domain | AAA_8 | 5.62e-03 | 14 | 152 | 2 | PF12780 | |
| Domain | DHC_fam | 6.44e-03 | 15 | 152 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.44e-03 | 15 | 152 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.44e-03 | 15 | 152 | 2 | IPR004273 | |
| Domain | AAA | 6.50e-03 | 144 | 152 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 6.50e-03 | 144 | 152 | 5 | IPR003593 | |
| Domain | - | 6.59e-03 | 47 | 152 | 3 | 3.30.420.10 | |
| Domain | HEAT | 6.99e-03 | 48 | 152 | 3 | PF02985 | |
| Domain | PH | 7.80e-03 | 278 | 152 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 7.94e-03 | 279 | 152 | 7 | PS50003 | |
| Domain | PH_domain | 8.09e-03 | 280 | 152 | 7 | IPR001849 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 1.86e-07 | 30 | 122 | 6 | M47738 | |
| Pathway | PID_TCPTP_PATHWAY | 1.51e-06 | 42 | 122 | 6 | M91 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 2.51e-06 | 12 | 122 | 4 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 2.51e-06 | 12 | 122 | 4 | MM15623 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 4.50e-06 | 29 | 122 | 5 | M47717 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | GRB10 GRB14 YWHAB STAT3 JAK1 APPL2 PIK3CA PIK3CB PIK3CG GAB1 | 5.30e-06 | 188 | 122 | 10 | MM15828 |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 6.83e-06 | 54 | 122 | 6 | M3896 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 7.47e-06 | 32 | 122 | 5 | M39445 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.16e-05 | 17 | 122 | 4 | MM15584 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.59e-05 | 129 | 122 | 8 | M186 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 2.31e-05 | 40 | 122 | 5 | M39798 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 3.31e-05 | 43 | 122 | 5 | M39788 | |
| Pathway | REACTOME_ABACAVIR_ADME | 3.43e-05 | 8 | 122 | 3 | MM14869 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.16e-05 | 23 | 122 | 4 | M47666 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 4.61e-05 | 46 | 122 | 5 | M48317 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 5.11e-05 | 9 | 122 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 5.11e-05 | 9 | 122 | 3 | M47490 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 5.87e-05 | 25 | 122 | 4 | M27865 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 7.26e-05 | 10 | 122 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 7.26e-05 | 10 | 122 | 3 | M47694 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 7.26e-05 | 10 | 122 | 3 | MM15833 | |
| Pathway | BIOCARTA_EIF2_PATHWAY | 7.26e-05 | 10 | 122 | 3 | MM1469 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 8.55e-05 | 121 | 122 | 7 | M39804 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 9.31e-05 | 28 | 122 | 4 | M2529 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 9.92e-05 | 11 | 122 | 3 | MM15405 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 1.07e-04 | 29 | 122 | 4 | MM1452 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.31e-04 | 12 | 122 | 3 | M14663 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 1.31e-04 | 12 | 122 | 3 | M45559 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.31e-04 | 12 | 122 | 3 | M27728 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 1.31e-04 | 12 | 122 | 3 | M29851 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 1.40e-04 | 31 | 122 | 4 | M46423 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.62e-04 | 134 | 122 | 7 | M3574 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.70e-04 | 13 | 122 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.70e-04 | 13 | 122 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.70e-04 | 13 | 122 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 1.70e-04 | 13 | 122 | 3 | M47603 | |
| Pathway | BIOCARTA_MET_PATHWAY | 1.80e-04 | 33 | 122 | 4 | M19358 | |
| Pathway | BIOCARTA_MET_PATHWAY | 1.80e-04 | 33 | 122 | 4 | MM1494 | |
| Pathway | WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME | 2.10e-04 | 63 | 122 | 5 | M45526 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.15e-04 | 14 | 122 | 3 | M47692 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 2.27e-04 | 35 | 122 | 4 | M127 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.62e-04 | 66 | 122 | 5 | MM15925 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.67e-04 | 15 | 122 | 3 | M39717 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 2.67e-04 | 15 | 122 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.67e-04 | 15 | 122 | 3 | M47663 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 2.97e-04 | 105 | 122 | 6 | M164 | |
| Pathway | REACTOME_RET_SIGNALING | 3.14e-04 | 38 | 122 | 4 | MM15493 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 3.14e-04 | 38 | 122 | 4 | M39854 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.26e-04 | 16 | 122 | 3 | M47695 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.26e-04 | 16 | 122 | 3 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.26e-04 | 16 | 122 | 3 | MM1420 | |
| Pathway | KEGG_PANCREATIC_CANCER | 3.45e-04 | 70 | 122 | 5 | M9726 | |
| Pathway | REACTOME_RET_SIGNALING | 3.84e-04 | 40 | 122 | 4 | M27746 | |
| Pathway | REACTOME_TIE2_SIGNALING | 3.94e-04 | 17 | 122 | 3 | MM14836 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 3.94e-04 | 17 | 122 | 3 | MM14790 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 4.47e-04 | 74 | 122 | 5 | M39857 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 4.69e-04 | 18 | 122 | 3 | M47761 | |
| Pathway | REACTOME_TIE2_SIGNALING | 4.69e-04 | 18 | 122 | 3 | M11932 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.69e-04 | 18 | 122 | 3 | M47659 | |
| Pathway | WP_INSULIN_SIGNALING | 4.78e-04 | 160 | 122 | 7 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 4.78e-04 | 160 | 122 | 7 | M39482 | |
| Pathway | WP_PROLACTIN_SIGNALING | 5.06e-04 | 76 | 122 | 5 | M39601 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 5.06e-04 | 76 | 122 | 5 | M9052 | |
| Pathway | REACTOME_PI_METABOLISM | 5.37e-04 | 77 | 122 | 5 | MM14590 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 5.54e-04 | 19 | 122 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.54e-04 | 19 | 122 | 3 | M47760 | |
| Pathway | WP_RETINOL_METABOLISM | 5.55e-04 | 44 | 122 | 4 | MM15851 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 5.55e-04 | 44 | 122 | 4 | M1012 | |
| Pathway | REACTOME_INTERLEUKIN_10_SIGNALING | 6.05e-04 | 45 | 122 | 4 | M27605 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 6.47e-04 | 20 | 122 | 3 | M47688 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE | 6.47e-04 | 20 | 122 | 3 | M29849 | |
| Pathway | BIOCARTA_IGF1MTOR_PATHWAY | 6.47e-04 | 20 | 122 | 3 | MM1496 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 7.14e-04 | 47 | 122 | 4 | M19708 | |
| Pathway | PID_IL6_7_PATHWAY | 7.14e-04 | 47 | 122 | 4 | M183 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY | 7.30e-04 | 5 | 122 | 2 | M49020 | |
| Pathway | WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER | 7.30e-04 | 5 | 122 | 2 | M39621 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY | 7.30e-04 | 5 | 122 | 2 | M48997 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 7.51e-04 | 21 | 122 | 3 | M47689 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 7.58e-04 | 83 | 122 | 5 | M39637 | |
| Pathway | PID_PI3KCI_PATHWAY | 7.74e-04 | 48 | 122 | 4 | M141 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 7.74e-04 | 48 | 122 | 4 | MM15441 | |
| Pathway | REACTOME_PI_METABOLISM | 8.00e-04 | 84 | 122 | 5 | M676 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 8.00e-04 | 84 | 122 | 5 | M39839 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.64e-04 | 22 | 122 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.64e-04 | 22 | 122 | 3 | M47675 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 9.38e-04 | 87 | 122 | 5 | MM15915 | |
| Pathway | KEGG_APOPTOSIS | 9.38e-04 | 87 | 122 | 5 | M8492 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 9.38e-04 | 87 | 122 | 5 | M39465 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 9.87e-04 | 23 | 122 | 3 | M18719 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.87e-04 | 23 | 122 | 3 | M47676 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 9.87e-04 | 23 | 122 | 3 | MM1480 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 1.04e-03 | 89 | 122 | 5 | M39732 | |
| Pathway | PID_KIT_PATHWAY | 1.05e-03 | 52 | 122 | 4 | M231 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 1.05e-03 | 52 | 122 | 4 | M7561 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 1.09e-03 | 6 | 122 | 2 | M27741 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 1.09e-03 | 6 | 122 | 2 | MM15489 | |
| Pathway | WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY | 1.12e-03 | 24 | 122 | 3 | M39399 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.12e-03 | 24 | 122 | 3 | M11520 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.17e-03 | 136 | 122 | 6 | M42547 | |
| Pathway | WP_IL4_SIGNALING | 1.21e-03 | 54 | 122 | 4 | M39720 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CAND1 AGO2 CAND2 RPLP0 SLC25A4 SLC25A5 SLC25A6 DSP RPLP0P6 POLE L2HGDH EIF2S3B TSC2 SAMHD1 YWHAB DRG1 USP10 RIF1 URB1 CYFIP1 MDN1 ANAPC1 EIF2S3 AGL DNAJC11 SNRNP200 TPI1 | 3.46e-11 | 1257 | 162 | 27 | 37317656 |
| Pubmed | 1.59e-09 | 12 | 162 | 5 | 16514418 | ||
| Pubmed | Appl1 is dispensable for Akt signaling in vivo and mouse T-cell development. | 1.59e-09 | 12 | 162 | 5 | 20665729 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CAND1 RPLP0 HSP90AB4P SLC25A5 DSP DYNC2H1 VPS13C POLE APOB SAMHD1 CYFIP2 DRG1 USP10 RIF1 URB1 CYFIP1 MDN1 ANAPC1 EIF2S3 PI4KA DNAJC11 GLS ZFR SNRNP200 TPI1 | 1.20e-08 | 1425 | 162 | 25 | 30948266 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CAND1 HSP90AB4P SLC25A4 SLC25A5 SLC25A6 MYO7A DSP TOPBP1 NIPSNAP2 NUF2 YWHAB CYFIP2 CYFIP1 MDN1 EIF2S3 DNAJC11 ZFR DNAH6 SNRNP200 | 1.82e-08 | 847 | 162 | 19 | 35235311 |
| Pubmed | 2.27e-08 | 19 | 162 | 5 | 24073214 | ||
| Pubmed | 3.04e-08 | 103 | 162 | 8 | 21706016 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 CAND1 AGO2 RPLP0 SLC25A5 SLC25A6 DSP DYNC2H1 DPP3 YWHAB CYFIP2 MDN1 EIF2S3 MOV10L1 CACNA1G SMS SNRNP200 TPI1 | 4.82e-08 | 807 | 162 | 18 | 30575818 |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | CAND1 AGO2 RPLP0 HSP90AB4P SLC25A4 SLC25A5 SLC25A6 RPLP0P6 YWHAB TPI1 | 6.05e-08 | 210 | 162 | 10 | 26217791 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYD88 CAND2 DSC2 SLC25A4 IDO1 MYO7A SULT1C4 CYFIP2 SH3BP4 ZCCHC14 CYFIP1 MDN1 APPL2 PIK3CB PIK3CG TTLL11 RBAK NMRK1 SMS ADAM17 PUS7L TPI1 | 8.39e-08 | 1242 | 162 | 22 | 30973865 |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2737681 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 9.92e-08 | 3 | 162 | 3 | 24787690 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3011597 | ||
| Pubmed | PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. | 9.92e-08 | 3 | 162 | 3 | 18187452 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 7840644 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 12450408 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 9.92e-08 | 3 | 162 | 3 | 15670660 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 9.92e-08 | 3 | 162 | 3 | 3157987 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2169444 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 9.92e-08 | 3 | 162 | 3 | 9145544 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 9.92e-08 | 3 | 162 | 3 | 6816803 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 17579043 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 35354963 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 11960985 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2474823 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 9.92e-08 | 3 | 162 | 3 | 23772048 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8163197 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 6756216 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 37806378 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 9.92e-08 | 3 | 162 | 3 | 2541251 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8018987 | ||
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 9.92e-08 | 3 | 162 | 3 | 2829183 | |
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 9.92e-08 | 3 | 162 | 3 | 33586683 | |
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 9.92e-08 | 3 | 162 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 9.92e-08 | 3 | 162 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 9.92e-08 | 3 | 162 | 3 | 10424757 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2347582 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 17908814 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 9.92e-08 | 3 | 162 | 3 | 7748347 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 3006456 | ||
| Pubmed | Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions. | 9.92e-08 | 3 | 162 | 3 | 21035500 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 9.92e-08 | 3 | 162 | 3 | 15554233 | |
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 6370228 | ||
| Pubmed | 9.92e-08 | 3 | 162 | 3 | 2935875 | ||
| Pubmed | 1.06e-07 | 223 | 162 | 10 | 20020773 | ||
| Pubmed | 1.46e-07 | 11 | 162 | 4 | 2565740 | ||
| Pubmed | SAMD9 RPLP0 SLC25A4 SLC25A5 SLC25A6 MYO7A DSP VPS13C EIF2S3B SAMHD1 YWHAB STAT3 DRG1 CYFIP1 EIF2S3 GLS TPI1 | 2.42e-07 | 803 | 162 | 17 | 36517590 | |
| Pubmed | CAND1 AGO2 RPLP0 SLC25A5 SLC25A6 RBMS1 POLE L2HGDH SAMHD1 DRG1 USP10 MDN1 EIF2S3 DNAJC11 ZFR SNRNP200 | 3.22e-07 | 725 | 162 | 16 | 27025967 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IPPK SLC25A5 MYO7A DSP VPS13C TSC2 SAMHD1 SLFN5 REV3L URB1 MDN1 PI4KA AGL PLXNA4 SNRNP200 ALOX5 | 3.93e-07 | 736 | 162 | 16 | 29676528 |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 8813054 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 12631290 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 17920279 | ||
| Pubmed | PI 3-kinase p110beta: a new target for antithrombotic therapy. | 3.95e-07 | 4 | 162 | 3 | 15834429 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 9733106 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 9202249 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 19618839 | ||
| Pubmed | Activity of any class IA PI3K isoform can sustain cell proliferation and survival. | 3.95e-07 | 4 | 162 | 3 | 20534549 | |
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 3.95e-07 | 4 | 162 | 3 | 3996732 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 9241435 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 23029326 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 15193143 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 2893758 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 11893554 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 33396658 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 29663519 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 12851412 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 36224745 | ||
| Pubmed | Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages. | 3.95e-07 | 4 | 162 | 3 | 19033389 | |
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 10880953 | ||
| Pubmed | 3.95e-07 | 4 | 162 | 3 | 9002638 | ||
| Pubmed | Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease. | 4.38e-07 | 14 | 162 | 4 | 26835538 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CAND1 SLC25A4 SLC25A6 POLE TOPBP1 SAMHD1 LARP4 DRG1 USP10 RIF1 URB1 MDN1 EIF2S3 ZFR TASOR SNRNP200 | 5.90e-07 | 759 | 162 | 16 | 35915203 |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 5.95e-07 | 15 | 162 | 4 | 9726281 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DSC2 DSP RASSF2 GRB10 TSC2 YWHAB STAT3 SH3BP4 ZCCHC14 SH3PXD2B MDN1 TIAM1 PI4KA DSTYK PLK4 GAB1 SPATA13 | 6.36e-07 | 861 | 162 | 17 | 36931259 |
| Pubmed | CAND1 RPLP0 HSP90AB4P SLC25A6 DSP L2HGDH APOB LARP4 RETSAT YWHAB STAT3 DRG1 JAK1 TBC1D13 USP10 CYFIP1 EIF2S3 GLS IFI30 ZFR ADI1 | 7.31e-07 | 1297 | 162 | 21 | 33545068 | |
| Pubmed | 7.90e-07 | 16 | 162 | 4 | 20019835 | ||
| Pubmed | 7.90e-07 | 16 | 162 | 4 | 15765518 | ||
| Pubmed | CAND1 AGO2 RPLP0 SLC25A4 SLC25A5 MYO7A DSP NIPSNAP2 EIF2S3B ABLIM3 YWHAB CYFIP2 USP10 CYFIP1 APPL2 PTPRS EIF2S3 PI4KA PLXNA4 DNAH6 SNRNP200 TPI1 | 9.19e-07 | 1431 | 162 | 22 | 37142655 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 11836246 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 1316195 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 9.85e-07 | 5 | 162 | 3 | 19193628 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 22084313 | ||
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 9.85e-07 | 5 | 162 | 3 | 22079585 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 31167146 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 8621625 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 27076174 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 7738026 | ||
| Pubmed | TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. | 9.85e-07 | 5 | 162 | 3 | 18590694 | |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 7579387 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 8892527 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 7026729 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 15664519 | ||
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 10358022 | ||
| Pubmed | 1.03e-06 | 17 | 162 | 4 | 25327288 | ||
| Pubmed | CAND1 CAND2 SLC25A4 DYNC2H1 POLE L2HGDH TSC2 RIF1 MDN1 ANAPC1 PI4KA AGL DNAJC11 TTI1 | 1.07e-06 | 606 | 162 | 14 | 36538041 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A POLE CYTH1 GRB10 TSC2 SMG5 JADE1 REV3L SH3BP4 ZCCHC14 SH3PXD2B URB1 MDN1 PTPRS PI4KA WDR90 ALOX5 MED13 SPATA13 | 1.07e-06 | 1105 | 162 | 19 | 35748872 |
| Pubmed | CAND1 AGO2 CAND2 VPS13C TOPBP1 SMG5 JADE1 USP10 SETBP1 CACNA1G WDR90 EIF2AK4 MED13 | 1.33e-06 | 529 | 162 | 13 | 14621295 | |
| Interaction | NPTN interactions | CAND2 SLC25A4 SLC25A5 SLC25A6 BZW2 DYNC2H1 TSC2 MDN1 FIG4 PI4KA DSTYK TTI1 | 1.81e-06 | 278 | 156 | 12 | int:NPTN |
| Interaction | GPR182 interactions | CAND1 CAND2 SLC25A4 SLC25A6 L2HGDH TSC2 RETSAT CYFIP2 JAK1 RIF1 URB1 MDN1 PI4KA TTI1 XPR1 | 2.64e-06 | 455 | 156 | 15 | int:GPR182 |
| Interaction | C9orf72 interactions | CAND1 AGO2 CAND2 RPLP0 SLC25A4 SLC25A5 SLC25A6 DSP RPLP0P6 POLE L2HGDH EIF2S3B TSC2 SAMHD1 YWHAB DRG1 USP10 RIF1 URB1 CYFIP1 MDN1 ANAPC1 EIF2S3 AGL DNAJC11 SNRNP200 TPI1 | 3.12e-06 | 1319 | 156 | 27 | int:C9orf72 |
| Interaction | PPT1 interactions | CAND1 AGO2 RPLP0 HSP90AB4P SLC25A4 SLC25A5 SLC25A6 RPLP0P6 YWHAB RIF1 TPI1 | 5.15e-06 | 256 | 156 | 11 | int:PPT1 |
| Interaction | PRKCE interactions | 8.32e-06 | 173 | 156 | 9 | int:PRKCE | |
| Interaction | DUSP16 interactions | DYNC2H1 VPS13C POLE TSC2 SMG5 NUF2 YWHAB ANAPC1 EIF2AK4 SNRNP200 | 1.64e-05 | 237 | 156 | 10 | int:DUSP16 |
| Interaction | HECTD1 interactions | CAND1 SLC25A4 SLC25A5 SLC25A6 RPLP0P6 POLE CAPN6 TOPBP1 SAMHD1 LARP4 YWHAB STAT3 DRG1 USP10 RIF1 URB1 MDN1 EIF2S3 ZFR TASOR SNRNP200 | 2.41e-05 | 984 | 156 | 21 | int:HECTD1 |
| Interaction | EEF1AKMT3 interactions | DSC2 HSP90AB4P VPS13C POLE TSC2 SLFN5 STAT3 MDN1 MOCS3 ANAPC1 PI4KA EIF2AK4 | 2.75e-05 | 364 | 156 | 12 | int:EEF1AKMT3 |
| Interaction | APLNR interactions | 4.03e-05 | 211 | 156 | 9 | int:APLNR | |
| Interaction | TIRAP interactions | 5.54e-05 | 53 | 156 | 5 | int:TIRAP | |
| Interaction | DCUN1D1 interactions | CAND1 RPLP0 SLC25A5 TRIM39 YWHAB COPS7A AGL VPS35L SNRNP200 UNC80 | 5.80e-05 | 275 | 156 | 10 | int:DCUN1D1 |
| Interaction | TOP3B interactions | AGO2 MYO7A RBMS1 POLE CYTH1 GRB10 TSC2 APOB SMG5 JADE1 REV3L LARP4 SH3BP4 ZCCHC14 USP10 SH3PXD2B ANOS1 URB1 MDN1 PTPRS PI4KA ZFR WDR90 ALOX5 MED13 SPATA13 | 6.10e-05 | 1470 | 156 | 26 | int:TOP3B |
| Interaction | MFSD4A interactions | 6.62e-05 | 225 | 156 | 9 | int:MFSD4A | |
| Interaction | ATG5 interactions | MYD88 VPS13C SAMHD1 YWHAB STAT3 JAK1 SH3PXD2B TIAM1 PI4KA AGL EIF2AK4 | 7.86e-05 | 344 | 156 | 11 | int:ATG5 |
| Cytoband | 4q23 | 6.93e-07 | 20 | 162 | 4 | 4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 9.01e-06 | 37 | 162 | 4 | chr4q23 | |
| GeneFamily | Alcohol dehydrogenases | 7.97e-06 | 8 | 96 | 3 | 397 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 7.97e-06 | 8 | 96 | 3 | 831 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-04 | 206 | 96 | 7 | 682 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.68e-03 | 161 | 96 | 5 | 593 | |
| GeneFamily | Tubulin tyrosine ligase family | 2.44e-03 | 14 | 96 | 2 | 779 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.80e-03 | 15 | 96 | 2 | 1296 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 SAMD9 SLF1 MYO7A RASSF2 VPS13C RBMS1 CYTH1 GATA3 SLFN5 JADE1 REV3L YWHAB STAT3 CYFIP2 JAK1 RIF1 LRRN3 CSF1 FAM111A DSTYK GLS NMRK1 ZFR CARD11 TASOR SNRNP200 MED13 USP47 SPATA13 | 9.51e-09 | 1492 | 162 | 30 | M40023 |
| Coexpression | LEE_BMP2_TARGETS_DN | MRPL20 CAND2 SLF1 TOPBP1 L2HGDH LARP4 RETSAT JAK1 USP10 RIF1 URB1 MDN1 FAM111A TIAM1 CARNMT1 ADI1 IL1R1 FST MCTP2 PLK4 PUS7L | 1.99e-07 | 904 | 162 | 21 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | MRPL20 CAND2 SLF1 TOPBP1 L2HGDH LARP4 RETSAT JAK1 USP10 RIF1 URB1 MDN1 FAM111A TIAM1 CARNMT1 ADI1 IL1R1 FST MCTP2 PLK4 PUS7L | 2.75e-07 | 922 | 162 | 21 | MM1068 |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 2.83e-06 | 242 | 162 | 10 | M12816 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | MYD88 SAMD9 DSC2 SLC25A5 CAPN6 NIPSNAP2 SLFN5 RETSAT ZDHHC3 YWHAB SH3BP4 SH3PXD2B CYFIP1 CSF1 SLC15A1 EIF2S3 IFI30 SMS ADI1 IL1R1 ALOX5 TPI1 | 1.32e-05 | 1276 | 162 | 22 | M39173 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | PEG3 GATA3 NLGN1 REV3L UBN2 ABLIM3 KLHL32 CYFIP2 ANOS1 URB1 GLS SCN7A PLXNA4 CACNA1G XPR1 | 3.29e-05 | 703 | 162 | 15 | M39070 |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 3.49e-05 | 199 | 162 | 8 | M9568 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 3.49e-05 | 199 | 162 | 8 | M8971 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP | 3.49e-05 | 199 | 162 | 8 | M5599 | |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN | 3.62e-05 | 200 | 162 | 8 | M391 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_UP | 3.62e-05 | 200 | 162 | 8 | M9572 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 3.62e-05 | 200 | 162 | 8 | M9570 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP | 3.62e-05 | 200 | 162 | 8 | M3865 | |
| Coexpression | GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP | 3.62e-05 | 200 | 162 | 8 | M7789 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN | 3.62e-05 | 200 | 162 | 8 | M5296 | |
| Coexpression | BROWNE_INTERFERON_RESPONSIVE_GENES | 6.01e-05 | 67 | 162 | 5 | M9221 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | AGO2 CAND2 RBMS1 POT1 TOPBP1 DPP3 CYFIP2 SH3BP4 ZNF713 CYFIP1 MDN1 PIK3CA PI4KA GLS ADI1 TM2D1 MCUB TASOR SNRNP200 PLK4 | 6.42e-05 | 1215 | 162 | 20 | M41122 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | MYD88 SAMD9 CYTH1 NIPSNAP2 GRB10 SAMHD1 SLFN5 REV3L RETSAT ZDHHC3 CSF1 PIK3CA PIK3CB SETBP1 NMRK1 ADAM17 MCUB TPI1 | 7.49e-05 | 1033 | 162 | 18 | M4196 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | MRPL20 CAND1 DSC2 SLC25A5 SLC25A6 PEG3 NIPSNAP2 GMPR2 YWHAB COPS7A USP10 LRRN3 ANOS1 PI4KA GLS ZFR ADAM17 ADI1 TM2D1 TPI1 | 9.26e-05 | 1248 | 162 | 20 | M17728 |
| Coexpression | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP | 1.17e-04 | 77 | 162 | 5 | M1992 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.28e-04 | 378 | 162 | 10 | M34022 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | AGO2 SLF1 VPS13C TOPBP1 L2HGDH SAMHD1 NUF2 JADE1 SH3BP4 COPS7A AGL DSTYK UGT8 IL1R1 PLK4 SPATA13 | 1.38e-04 | 892 | 162 | 16 | M18120 |
| Coexpression | LTE2_UP.V1_UP | 1.75e-04 | 188 | 162 | 7 | M2723 | |
| Coexpression | GREENBAUM_E2A_TARGETS_DN | 1.77e-04 | 18 | 162 | 3 | M1457 | |
| Coexpression | PGF_UP.V1_UP | 1.86e-04 | 190 | 162 | 7 | M2674 | |
| Coexpression | GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN | 2.33e-04 | 197 | 162 | 7 | M3255 | |
| Coexpression | ERBB2_UP.V1_DN | 2.33e-04 | 197 | 162 | 7 | M2635 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 2.40e-04 | 198 | 162 | 7 | M9407 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.40e-04 | 198 | 162 | 7 | M8969 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 2.47e-04 | 199 | 162 | 7 | M9595 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN | 2.47e-04 | 199 | 162 | 7 | M9913 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 2.47e-04 | 199 | 162 | 7 | M7190 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.47e-04 | 199 | 162 | 7 | M5251 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_DC_UP | 2.47e-04 | 199 | 162 | 7 | M5399 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 2.47e-04 | 199 | 162 | 7 | M9173 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 2.47e-04 | 199 | 162 | 7 | M5607 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP | 2.55e-04 | 200 | 162 | 7 | M4574 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M3527 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN | 2.55e-04 | 200 | 162 | 7 | M9688 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN | 2.55e-04 | 200 | 162 | 7 | M9597 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP | 2.55e-04 | 200 | 162 | 7 | M9542 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 2.55e-04 | 200 | 162 | 7 | M9586 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP | 2.55e-04 | 200 | 162 | 7 | M3749 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP | 2.55e-04 | 200 | 162 | 7 | M6158 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_DN | 2.55e-04 | 200 | 162 | 7 | M3802 | |
| Coexpression | GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN | 2.55e-04 | 200 | 162 | 7 | M6425 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP | 2.55e-04 | 200 | 162 | 7 | M5129 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.55e-04 | 200 | 162 | 7 | M8967 | |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | 2.63e-04 | 201 | 162 | 7 | M2200 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CAND1 AGO2 RBMS1 CYTH1 TOPBP1 REV3L LARP4 ABLIM3 RIF1 MDN1 TIAM1 ADAM17 IL1R1 TASOR MED13 | 2.88e-04 | 856 | 162 | 15 | M4500 |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 2.99e-04 | 94 | 162 | 5 | M18108 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | DYNC2H1 RBMS1 ABLIM3 ADH1B LRRN3 CSF1 PTPRS SCN7A PTCH2 IL1R1 FST | 3.20e-04 | 505 | 162 | 11 | M39167 |
| Coexpression | GREENBAUM_E2A_TARGETS_DN | 3.27e-04 | 22 | 162 | 3 | MM635 | |
| Coexpression | BECKER_TAMOXIFEN_RESISTANCE_DN | 3.50e-04 | 54 | 162 | 4 | M15676 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CAND2 SLF1 POLE PEG3 SAMHD1 NUF2 JADE1 JAK1 RIF1 FAM111A WDR90 PLK4 | 3.55e-04 | 597 | 162 | 12 | MM1309 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | SLF1 POT1 TOPBP1 JADE1 YWHAB RIF1 ANAPC1 RBAK SNRNP200 PUS7L | 3.87e-04 | 434 | 162 | 10 | M15150 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DYNC2H1 VPS13C PEG3 REV3L KLHL32 CYFIP2 RIF1 ZFR RESP18 UNC80 | 2.71e-09 | 195 | 162 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DYNC2H1 VPS13C PEG3 REV3L KLHL32 CYFIP2 RIF1 ZFR RESP18 UNC80 | 2.71e-09 | 195 | 162 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.88e-07 | 184 | 162 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.15e-07 | 191 | 162 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.02e-07 | 195 | 162 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-07 | 197 | 162 | 8 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 171 | 162 | 7 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 171 | 162 | 7 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 3.15e-06 | 171 | 162 | 7 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 171 | 162 | 7 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.67e-06 | 175 | 162 | 7 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-06 | 182 | 162 | 7 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-06 | 182 | 162 | 7 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 191 | 162 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 191 | 162 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 191 | 162 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 191 | 162 | 7 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-06 | 191 | 162 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-06 | 192 | 162 | 7 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 6.74e-06 | 192 | 162 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 6.97e-06 | 193 | 162 | 7 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.97e-06 | 193 | 162 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | CV-Moderate-5|Moderate / Virus stimulation, Condition and Cluster | 7.46e-06 | 195 | 162 | 7 | 646d06ac3fa20acb172735c88cf45e01d212cebf | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.46e-06 | 195 | 162 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.46e-06 | 195 | 162 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.71e-06 | 196 | 162 | 7 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.71e-06 | 196 | 162 | 7 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.71e-06 | 196 | 162 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.97e-06 | 197 | 162 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.24e-06 | 198 | 162 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.24e-06 | 198 | 162 | 7 | c4d8d133e571ad3a7c5de93aa7befb67cb7a003d | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 8.24e-06 | 198 | 162 | 7 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.24e-06 | 198 | 162 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.24e-06 | 198 | 162 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.24e-06 | 198 | 162 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.24e-06 | 198 | 162 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.24e-06 | 198 | 162 | 7 | db107a5511571384f26e26c6301aef9a9f2423c4 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.24e-06 | 198 | 162 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 8.51e-06 | 199 | 162 | 7 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.51e-06 | 199 | 162 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 8.51e-06 | 199 | 162 | 7 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.51e-06 | 199 | 162 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 8.79e-06 | 200 | 162 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.79e-06 | 200 | 162 | 7 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.79e-06 | 200 | 162 | 7 | ef42753c9fbe3770e3f415cd7ab412654d359edb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-05 | 154 | 162 | 6 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-05 | 155 | 162 | 6 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-05 | 160 | 162 | 6 | 709ce00699ca05346287868ea55a1affae0859a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 164 | 162 | 6 | 83141be8dfed85511ea6afda7c76ff4b6b5ef021 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-05 | 166 | 162 | 6 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 166 | 162 | 6 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 169 | 162 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.00e-05 | 172 | 162 | 6 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 4.26e-05 | 174 | 162 | 6 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.40e-05 | 175 | 162 | 6 | 16c835e62a3321f6cf6163954889946bbb869498 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 176 | 162 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 176 | 162 | 6 | 8488997e0f02e874f53fae1690da63e0dd1d0780 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.69e-05 | 177 | 162 | 6 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 4.69e-05 | 177 | 162 | 6 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.69e-05 | 177 | 162 | 6 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 4.84e-05 | 178 | 162 | 6 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-05 | 178 | 162 | 6 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 4.99e-05 | 179 | 162 | 6 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.99e-05 | 179 | 162 | 6 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 5.15e-05 | 180 | 162 | 6 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.31e-05 | 181 | 162 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 5.31e-05 | 181 | 162 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 5.31e-05 | 181 | 162 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 5.64e-05 | 183 | 162 | 6 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-05 | 183 | 162 | 6 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.64e-05 | 183 | 162 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.99e-05 | 185 | 162 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 185 | 162 | 6 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.17e-05 | 186 | 162 | 6 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-05 | 186 | 162 | 6 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 187 | 162 | 6 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-05 | 187 | 162 | 6 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.36e-05 | 187 | 162 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 188 | 162 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 189 | 162 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 6.74e-05 | 189 | 162 | 6 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.74e-05 | 189 | 162 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 189 | 162 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 190 | 162 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.94e-05 | 190 | 162 | 6 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 190 | 162 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.94e-05 | 190 | 162 | 6 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.15e-05 | 191 | 162 | 6 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 191 | 162 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 191 | 162 | 6 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | CV-Mild-5|CV / Virus stimulation, Condition and Cluster | 7.15e-05 | 191 | 162 | 6 | cf40d2b3daeb968b05b4dc2a0a9dc3eb9a0cccfa | |
| ToppCell | CV-Severe-5|Severe / Virus stimulation, Condition and Cluster | 7.15e-05 | 191 | 162 | 6 | d04f93fc85c882260ca4d5b4768504fbf8a47984 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-05 | 192 | 162 | 6 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-05 | 192 | 162 | 6 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-05 | 192 | 162 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-05 | 192 | 162 | 6 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.35e-05 | 192 | 162 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| Drug | 4-Iodopyrazole | 3.41e-07 | 3 | 160 | 3 | DB02721 | |
| Drug | Clodronate | 3.41e-07 | 3 | 160 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 1.36e-06 | 4 | 160 | 3 | ctd:C000600819 | |
| Drug | Fomepizole | 1.36e-06 | 4 | 160 | 3 | DB01213 | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 3.80e-06 | 34 | 160 | 5 | ctd:C569670 | |
| Drug | IDR-E804 | 6.71e-06 | 6 | 160 | 3 | CID006419764 | |
| Drug | AC1OAGKW | 9.39e-06 | 193 | 160 | 9 | CID006857413 | |
| Drug | pyridone 6 | 9.83e-06 | 41 | 160 | 5 | CID005494425 | |
| Drug | Ethanol | 1.17e-05 | 7 | 160 | 3 | DB00898 | |
| Drug | closantel | 1.17e-05 | 7 | 160 | 3 | ctd:C023342 | |
| Drug | ursolic acid | 1.17e-05 | 72 | 160 | 6 | CID000064945 | |
| Drug | phenylsuccinate | 1.28e-05 | 21 | 160 | 4 | CID000095459 | |
| Drug | N-heptylformamide | 1.86e-05 | 8 | 160 | 3 | CID000347402 | |
| Drug | phenylarsine oxide | SLC25A4 ACTRT3 SLC25A5 SLC25A6 APOB PTPRS EIF2S3 PI4KA IL1R1 GAB1 | 2.60e-05 | 275 | 160 | 10 | CID000004778 |
| Drug | 2-NA | 2.77e-05 | 9 | 160 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 2.77e-05 | 9 | 160 | 3 | CID000440672 | |
| Drug | ZSTK474 | 2.77e-05 | 9 | 160 | 3 | ctd:C510150 | |
| Drug | beta-estradiol 3-benzoate | 3.44e-05 | 128 | 160 | 7 | CID000003262 | |
| Drug | N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo(d)thiazol-2-yl)acetamide | 3.94e-05 | 10 | 160 | 3 | ctd:C558744 | |
| Drug | AC1L4X2K | 3.94e-05 | 10 | 160 | 3 | CID000193824 | |
| Drug | deguelin | 4.22e-05 | 55 | 160 | 5 | CID000107935 | |
| Drug | AC1OAGFW | 4.90e-05 | 184 | 160 | 8 | CID006857352 | |
| Drug | LFM A13 | 4.91e-05 | 2 | 160 | 2 | ctd:C118451 | |
| Drug | AC1L1J0I | 7.15e-05 | 12 | 160 | 3 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 7.15e-05 | 12 | 160 | 3 | CID000008104 | |
| Drug | LY294002 | MYD88 ACTRT3 IDO1 CYTH1 GRB10 TSC2 STAT3 JAK1 CSF1 PIK3CA PIK3CB PIK3CG PI4KA IL1R1 IL36G GAB1 | 7.85e-05 | 748 | 160 | 16 | CID000003973 |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 2294_UP | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 5727_UP | |
| Drug | AC1OAGKB | 8.20e-05 | 198 | 160 | 8 | CID006857406 | |
| Drug | 2-naphthaldehyde | 9.25e-05 | 13 | 160 | 3 | CID000006201 | |
| Drug | 3-methylbutanal | 9.25e-05 | 13 | 160 | 3 | CID000011552 | |
| Disease | Mouth Neoplasms | 4.48e-07 | 54 | 158 | 6 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 4.48e-07 | 54 | 158 | 6 | C0153381 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 6.00e-07 | 4 | 158 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.16e-05 | 55 | 158 | 5 | C0079744 | |
| Disease | ovarian cancer (is_implicated_in) | 1.27e-05 | 56 | 158 | 5 | DOID:2394 (is_implicated_in) | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 2.85e-05 | 2 | 158 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | Down syndrome (biomarker_via_orthology) | 2.85e-05 | 2 | 158 | 2 | DOID:14250 (biomarker_via_orthology) | |
| Disease | age-related hearing impairment | 6.66e-05 | 324 | 158 | 9 | EFO_0005782 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 8.52e-05 | 3 | 158 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | isoleucine measurement | 2.34e-04 | 56 | 158 | 4 | EFO_0009793 | |
| Disease | Alcohol dependence | 2.82e-04 | 5 | 158 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 2.82e-04 | 5 | 158 | 2 | 103780 | |
| Disease | angiomyolipoma (is_marker_for) | 2.82e-04 | 5 | 158 | 2 | DOID:3314 (is_marker_for) | |
| Disease | mean corpuscular hemoglobin concentration | MYD88 SAMD9 AGO2 ACTRT3 BZW2 POT1 GRB14 TSC2 SMG5 GMPR2 STAT3 RIF1 PIK3CA EIF2AK4 PLK4 MED13 | 3.04e-04 | 1105 | 158 | 16 | EFO_0004528 |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.58e-04 | 26 | 158 | 3 | DOID:234 (is_implicated_in) | |
| Disease | hypopituitarism (implicated_via_orthology) | 4.21e-04 | 6 | 158 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 4.47e-04 | 28 | 158 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | Carcinoma, Basal Cell | 4.97e-04 | 29 | 158 | 3 | C4721806 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 4.97e-04 | 29 | 158 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 4.98e-04 | 121 | 158 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Squamous cell carcinoma | 5.57e-04 | 124 | 158 | 5 | C0007137 | |
| Disease | Eosinophilia, Tropical | 5.88e-04 | 7 | 158 | 2 | C0014458 | |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 5.88e-04 | 7 | 158 | 2 | cv:C0349788 | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 6.06e-04 | 31 | 158 | 3 | C0023493 | |
| Disease | Inflammation | 6.21e-04 | 127 | 158 | 5 | C0021368 | |
| Disease | Alcoholic Intoxication, Chronic | 6.27e-04 | 268 | 158 | 7 | C0001973 | |
| Disease | cancer (implicated_via_orthology) | 6.27e-04 | 268 | 158 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | nucleotide measurement | 6.46e-04 | 73 | 158 | 4 | EFO_0010513 | |
| Disease | Eosinophilia | 7.81e-04 | 8 | 158 | 2 | C0014457 | |
| Disease | Unilateral agenesis of kidney | 7.81e-04 | 8 | 158 | 2 | C0266294 | |
| Disease | unipolar depression, alcohol dependence | 8.30e-04 | 78 | 158 | 4 | EFO_0003761, MONDO_0007079 | |
| Disease | serum alanine aminotransferase measurement | NIPSNAP2 GRB14 L2HGDH APOB CYFIP2 ADH1B C4orf17 ZNF713 DSTYK IFI30 IL1R1 IL36G ALOX5 | 8.41e-04 | 869 | 158 | 13 | EFO_0004735 |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 8.69e-04 | 35 | 158 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | waist-hip ratio | IPPK CAND2 DYNC2H1 RBMS1 GRB10 ABLIM3 KLHL32 ADH1B ADAMTS10 SH3PXD2B PTPRS DSTYK SETBP1 GLS TTC12 ADAM17 | 9.30e-04 | 1226 | 158 | 16 | EFO_0004343 |
| Disease | triacylglycerol 52:4 measurement | 9.45e-04 | 36 | 158 | 3 | EFO_0010416 | |
| Disease | leukodystrophy (implicated_via_orthology) | 1.00e-03 | 9 | 158 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Adult Hepatocellular Carcinoma | 1.00e-03 | 9 | 158 | 2 | C0279607 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.02e-03 | 37 | 158 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | late-onset Alzheimers disease | 1.03e-03 | 292 | 158 | 7 | EFO_1001870 | |
| Disease | Stomach Neoplasms | 1.14e-03 | 297 | 158 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.21e-03 | 300 | 158 | 7 | C0024623 | |
| Disease | medulloblastoma (is_implicated_in) | 1.25e-03 | 10 | 158 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.25e-03 | 10 | 158 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Head and Neck Carcinoma | 1.25e-03 | 10 | 158 | 2 | C3887461 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.38e-03 | 41 | 158 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.38e-03 | 41 | 158 | 3 | C0858252 | |
| Disease | Colorectal Carcinoma | RASSF2 POLE PEG3 CAPN6 APOB ADH1B TIAM1 PIK3CA PTPRS SETBP1 SNRNP200 | 1.46e-03 | 702 | 158 | 11 | C0009402 |
| Disease | Childhood Medulloblastoma | 1.59e-03 | 43 | 158 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 1.59e-03 | 43 | 158 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 1.59e-03 | 43 | 158 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 1.59e-03 | 43 | 158 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 1.59e-03 | 43 | 158 | 3 | C0278876 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.70e-03 | 44 | 158 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | diffuse large B-cell lymphoma (is_implicated_in) | 1.82e-03 | 12 | 158 | 2 | DOID:0050745 (is_implicated_in) | |
| Disease | esophageal cancer (is_marker_for) | 1.82e-03 | 12 | 158 | 2 | DOID:5041 (is_marker_for) | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.82e-03 | 12 | 158 | 2 | C0023485 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.82e-03 | 12 | 158 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | IDO1 DYNC2H1 GATA3 CFHR5 SPAG6 STAT3 ZCCHC14 RIF1 CSF1 PIK3CA PIK3CB SETBP1 FST GAB1 | 1.97e-03 | 1074 | 158 | 14 | C0006142 |
| Disease | Cardiomyopathy | 2.06e-03 | 47 | 158 | 3 | cv:C0878544 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 2.14e-03 | 13 | 158 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 2.14e-03 | 13 | 158 | 2 | C1261502 | |
| Disease | Weight Gain | 2.24e-03 | 102 | 158 | 4 | C0043094 | |
| Disease | Leukemia, Myelocytic, Acute | 2.45e-03 | 173 | 158 | 5 | C0023467 | |
| Disease | Medulloblastoma | 2.46e-03 | 50 | 158 | 3 | C0025149 | |
| Disease | Adenocarcinoma Of Esophagus | 2.49e-03 | 14 | 158 | 2 | C0279628 | |
| Disease | Breast Carcinoma | 2.55e-03 | 538 | 158 | 9 | C0678222 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.75e-03 | 52 | 158 | 3 | C1168401 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.75e-03 | 108 | 158 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | Epilepsy | 2.85e-03 | 109 | 158 | 4 | C0014544 | |
| Disease | alcohol dependence measurement | 3.22e-03 | 55 | 158 | 3 | EFO_0007835 | |
| Disease | Chronic Lymphocytic Leukemia | 3.22e-03 | 55 | 158 | 3 | C0023434 | |
| Disease | alcohol use disorder (is_implicated_in) | 3.25e-03 | 16 | 158 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Carcinoma, Granular Cell | 3.56e-03 | 116 | 158 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.56e-03 | 116 | 158 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.56e-03 | 116 | 158 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.56e-03 | 116 | 158 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.56e-03 | 116 | 158 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.56e-03 | 116 | 158 | 4 | C0001418 | |
| Disease | Benign neoplasm of stomach | 3.68e-03 | 17 | 158 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.68e-03 | 17 | 158 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.68e-03 | 17 | 158 | 2 | C0154060 | |
| Disease | serine measurement, amino acid measurement | 3.68e-03 | 17 | 158 | 2 | EFO_0005134, EFO_0009774 | |
| Disease | Myeloid Leukemia | 4.12e-03 | 18 | 158 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 4.12e-03 | 18 | 158 | 2 | C0023466 | |
| Disease | glucose measurement | 4.51e-03 | 380 | 158 | 7 | EFO_0004468 | |
| Disease | Usual Interstitial Pneumonia | 4.59e-03 | 19 | 158 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.59e-03 | 19 | 158 | 2 | C4721508 | |
| Disease | corneal hysteresis | 5.08e-03 | 20 | 158 | 2 | EFO_0010066 | |
| Disease | serum homoarginine measurement | 5.08e-03 | 20 | 158 | 2 | EFO_0005421 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.08e-03 | 20 | 158 | 2 | C4721952 | |
| Disease | Hereditary Diffuse Gastric Cancer | 5.09e-03 | 293 | 158 | 6 | C1708349 | |
| Disease | Cardiomyopathies | 5.33e-03 | 130 | 158 | 4 | C0878544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NEILNYKDLAALPKV | 301 | O94929 | |
| LSQECPIKEVVLYVK | 266 | Q9Y6E2 | |
| CNDVLELLDKYLIPN | 96 | P31946 | |
| YKGIVDCIVRIPKEQ | 51 | P12236 | |
| AKVKCIPYAVLLEAL | 106 | Q9UBW8 | |
| ERDACYQPIIKEILK | 176 | Q8N4J0 | |
| PKQRYLKLVCDEIYN | 1611 | Q9P2K8 | |
| DCLEKVYQLPDGKVI | 231 | Q9BYD9 | |
| CINPQDYKKPIQEVL | 241 | P07327 | |
| CINPQDYKKPIQEVL | 241 | P00325 | |
| CINPQDYKKPIQEVL | 241 | P00326 | |
| YKGIIDCVVRIPKEQ | 51 | P05141 | |
| DLCVRYENNLKPVLK | 1316 | O60706 | |
| KTNEGVLCVVKPLNY | 411 | Q02487 | |
| VLCVVKPLNYEEKQQ | 416 | Q02487 | |
| DVNKVAYCPLVLKFQ | 1071 | Q9H324 | |
| CIKLEKDYQPGITFI | 691 | Q9UKV8 | |
| VKPECLEAYNKICQE | 81 | O75323 | |
| LEAYNKICQEVLPKI | 86 | O75323 | |
| QDLVKLCQPYGKIVS | 76 | P29558 | |
| PCGQDKYISKNELLL | 11 | P50749 | |
| ICYNGEIPLKDKTLI | 786 | P23458 | |
| PLEFVKQLCLKIQSE | 81 | Q9H8X2 | |
| SCVKPLKYAIAVNDL | 286 | O94925 | |
| NVPYIPAEKNIDLCK | 166 | P0C860 | |
| CLQAIKFILPKEIAV | 621 | Q9H1A4 | |
| KENIPLKLSEDCLYL | 106 | Q9UKY3 | |
| VKCNEQPNRVEIYEK | 96 | Q7L576 | |
| EFLKYILLVKQGDCP | 121 | P23352 | |
| DPCVGEEKNLKVLYQ | 516 | Q9NVH1 | |
| NIAVPYCQLSKKLEL | 106 | P14902 | |
| FCQLYKPEIVINELD | 611 | Q9NU22 | |
| PSDVQKVQYAELKLC | 851 | Q6DN12 | |
| LVINKIAYDVQCPKR | 136 | Q9NWR8 | |
| KCVEQKIDILTFQPL | 506 | Q9BXT6 | |
| IPCIYVLNKIDQISI | 241 | Q9Y295 | |
| PVYVGINEAKKNCII | 141 | A8MVJ9 | |
| LIQQEDIKKKEPYCR | 166 | Q9H9P8 | |
| QDYLLLINCQSKKPE | 181 | Q13480 | |
| CLIAVYLEKEPEKEI | 186 | Q58FF6 | |
| CLGPLVSKVKEYQVE | 71 | Q86VP6 | |
| EYLEKIIPLVVKFCN | 251 | Q86VP6 | |
| NVKLNYTVLVGEKPC | 1176 | Q9HCM2 | |
| LLCAEPQVKEQVKLY | 276 | Q6ZWH5 | |
| LPSCQLEVQLYQKKI | 286 | Q9BZD4 | |
| LYIPDNKDQVIKACK | 326 | Q15438 | |
| LEIQDKEYLCKYAIP | 171 | P42356 | |
| VDVKLISPQDCTKVY | 166 | P49862 | |
| GPSIEEDCQKYILKQ | 106 | Q99836 | |
| YAPILQKVVEQLEKA | 251 | Q9NY33 | |
| ILEAIPQVKYICLDV | 116 | Q9P2T1 | |
| ECQHVVKAKLAQIYP | 351 | Q96KJ4 | |
| LLNNPALEFIKYVCK | 2096 | Q07864 | |
| LKARCKEQPELEVQY | 146 | P19883 | |
| KEQPELEVQYQGRCK | 151 | P19883 | |
| VECLQKKPYKELVDQ | 371 | Q8N2Q7 | |
| VKCNEQPNRVEIYEK | 96 | Q96F07 | |
| KIIQLLDDYPKCFIV | 16 | P05388 | |
| CYKIPQLENKDLEKL | 426 | Q9C091 | |
| FPPKEEKYLQQIVDC | 96 | Q6XUX3 | |
| EKYLQQIVDCLPCIL | 101 | Q6XUX3 | |
| PENCEKLVTLLENYK | 111 | Q9GZU2 | |
| KYTLKINHDCVPEQV | 206 | P42336 | |
| RVVVKYKPVALQCIA | 1836 | Q96RW7 | |
| IICIVIAILLYKNKP | 1296 | Q13332 | |
| LKQEVANPVKITYRC | 176 | Q5W5W9 | |
| ARQDEKECLKYQVPL | 176 | P23771 | |
| PNQIKKALELYEQLC | 1956 | Q8NCM8 | |
| CERLVLYLKDINLPK | 2351 | Q8NCM8 | |
| IPYVFKLLKENLCLN | 4341 | P04114 | |
| LLEYDKENIKPQILA | 2841 | Q9C0G6 | |
| LYCEKVGEQPTLQLK | 86 | Q9NZH8 | |
| KDLNRDKIYLICQIV | 286 | Q92608 | |
| DQEQLKDPVCYLKKA | 71 | P09603 | |
| PQILDEALKICNYIF | 1636 | O43497 | |
| LLTLVCQLYQGKKPD | 221 | P13284 | |
| PYDEVICAVNLKKLI | 646 | Q92562 | |
| YGEKKQIDACAVIPQ | 476 | Q96PZ2 | |
| IILRALCDYKQDQKI | 461 | P15924 | |
| ICIPNYLDQEIKILA | 171 | Q53FE4 | |
| EKELYEALVKVINNP | 406 | Q16880 | |
| INQECILQKPIYTII | 101 | A6NN92 | |
| CYAINLGKEIIEVQK | 606 | Q8NEU8 | |
| EKVAVLCKENYLLPE | 411 | Q9BXR6 | |
| LCKENYLLPEAKEIV | 416 | Q9BXR6 | |
| LQEPRKLSYAEVCQK | 611 | Q71RC2 | |
| LVEFYQLNKGVLPCK | 516 | Q14449 | |
| VDFYQLNKGVLPCKL | 571 | Q13322 | |
| SQEKYKTLQCLNIPE | 901 | Q6PJP8 | |
| NIEVVCEYIVKKIPV | 231 | Q2VIR3 | |
| ENQLIYPVKKCQERD | 91 | Q4AE62 | |
| TVNPYLVIKCGKEEV | 536 | Q9Y6Q1 | |
| CLGPLVVKVKEYQVE | 71 | O75155 | |
| YIVQRKNDSCPEVKV | 556 | P46059 | |
| LPEVLEKQCGYKLFI | 411 | P14778 | |
| KLTPYLRQCKVIDEQ | 41 | Q9BXL7 | |
| VPIYVICKLGNDSQK | 406 | O95396 | |
| CLFLYVKPKQTQGVE | 251 | Q8NGT5 | |
| VYEDLIQELAKQKCL | 181 | Q9NWW6 | |
| VKKGHELVNIYCPIV | 336 | Q6NUM9 | |
| KIIQLLDDYPKCFIV | 16 | Q8NHW5 | |
| VLIEDCIPVLKRYAK | 251 | P52788 | |
| ATQEYKEKLQKCLEP | 146 | Q9HCM9 | |
| LKYPALIGNLVKCQV | 81 | Q9BYC9 | |
| DLLLPEQIIKYLCKS | 206 | Q8TBZ9 | |
| KCDILPQLVYSLAEQ | 81 | O75602 | |
| LILCNKTAYQEVFKP | 36 | Q9UPR3 | |
| NAKEVIAIKDYCPTN | 56 | Q9P0V3 | |
| LPEKFAEQLIRVYCK | 541 | Q9Y3Z3 | |
| CLLYKNLANKIVPIA | 311 | P09917 | |
| ICIDIPTIYQKNRKK | 591 | Q9H3W5 | |
| VVKPNLEYKELCHLV | 196 | Q9H0K6 | |
| LDEVPKVYSCLNNKL | 871 | Q5UIP0 | |
| KYIRYEKPLVIILNC | 821 | Q5K651 | |
| LNKICYKSGVPLIEN | 156 | Q9Y6C5 | |
| QYLERTPLCAILKQK | 341 | Q9NUX5 | |
| KPETNYKIQELQCQI | 716 | Q5VXU9 | |
| CKKPLKVSDELVQQY | 661 | Q9UHV7 | |
| EIVPKCNGSLIKVNY | 716 | Q6IE81 | |
| QLVQVLKYEPFLDCA | 641 | P42338 | |
| NEKLPDYIKQKLQCL | 941 | O00444 | |
| VNILKVCPDLLNKYF | 361 | O60287 | |
| VYQLPICKLKELFEE | 611 | Q9UK61 | |
| VVNNIKEKLCYIALE | 211 | Q8TDG2 | |
| PKVCGYLKVDNEELL | 181 | P78536 | |
| YKGIIDCVVRIPKEQ | 51 | P12235 | |
| KREIYNPKSVVLDLC | 521 | Q96M20 | |
| KDLPKGALLNLQIYC | 421 | P48736 | |
| QKICKYPLQLAELLK | 381 | Q96N96 | |
| EVAPFYTCKKINQLI | 181 | Q9UBH6 | |
| CSLVIQQEVYPKEKS | 441 | O75820 | |
| VQEYICKPLLIDKLK | 371 | Q8NHH1 | |
| EECVKLLTNPQALLY | 11 | Q49A33 | |
| VQKYIETPLLICDTK | 391 | A6PVC2 | |
| IYNLCQKQVVEKIPL | 1661 | Q96KV7 | |
| LVEIKLGCYELEPNK | 616 | Q6ZU65 | |
| KVITKLKNPQDYINC | 491 | Q7Z3J2 | |
| EALVPCYLQKLKRQT | 2371 | Q8N2C7 | |
| NIERKPEYLQPEKCV | 11 | Q9NYG2 | |
| LLYKEIEICPKVTQS | 831 | Q13009 | |
| VKLKFEKVYLPCVLQ | 2816 | O60673 | |
| AVKRLIPIDEYCKAL | 91 | A1X283 | |
| PELNYQLKIKVCIDK | 356 | P40763 | |
| QKISILEKPFEYNEC | 196 | Q9NYW8 | |
| LEKNCKIIYVARNPK | 126 | O75897 | |
| KVYQLLVNEQEPCKF | 1126 | Q96K76 | |
| LKVGQYICKDPKIND | 51 | Q9BX74 | |
| LDPKIAVAAQNCYKV | 56 | P60174 | |
| QKVIYYLCILLKDPV | 131 | Q14442 | |
| YPITDVCQILQKAKE | 381 | Q9NVG8 | |
| PCILNEADKIIYKLI | 236 | Q709C8 | |
| CIRIDKQPVYNVEVK | 391 | Q9BQI6 | |
| EDVYIVKNKPVLLVC | 51 | Q6ZN44 | |
| AEQCKNLELKDLLPY | 766 | O75643 | |
| ISKLCQLYPEENLEK | 141 | Q8WYQ9 | |
| QLAVISPEKYDIKCA | 831 | Q96KR1 | |
| GCQKLIKNIEYPVDL | 696 | Q14694 | |
| CYKKILEINPKLQTQ | 196 | Q9H892 | |
| YVLLKILCKTQNVPK | 761 | Q01118 | |
| LGYQLCKPEVIAQLE | 71 | Q8N859 | |
| ENYICPPEIKITIKQ | 121 | Q9Y6X0 | |
| LIVQEPKGQKYECAK | 241 | Q92547 | |
| LGLYICQKLDIFAPK | 56 | Q7Z769 | |
| ILYICENQPLKKLVS | 606 | Q08AF3 | |
| LIELKDCQPDKVYLG | 1581 | P49815 | |
| KVADACLIYLSVKQP | 1006 | O43156 | |
| CLIYLSVKQPVKLQE | 1011 | O43156 | |
| VPYRLNEITKEKEQC | 1066 | P35573 | |
| NIEVVCEYIVKKIPV | 231 | P41091 | |
| VCKVKELRYFNPVDQ | 301 | Q96NJ5 | |
| IITICKDKLPNYEEK | 66 | Q9BV57 | |
| AEPLKDEAYVQILKQ | 1806 | Q13402 |